首页 > 最新文献

Open Journal of Asthma最新文献

英文 中文
Immunosenescence and ACE2 protein expression: Association with SARS-CoV-2 in older adults 老年人免疫衰老和ACE2蛋白表达:与SARS-CoV-2相关
Pub Date : 2022-10-29 DOI: 10.17352/oja.000018
Altamirano Gustavo Acosta, Rodríguez Carlos E Miguel, Reyes-Montes María del Rocío, Duarte-Escalante Esperanza, Acosta-Reyes Rocío, Torres-Estrella Carlos U, Valencia-Ledezma Omar E
At the end of 2019, in Wuhan, China, an outbreak of cases of respiratory tract infection emerged and its progressive infection mainly affects adults, generating many cases of pneumonia. A type of coronavirus named SARS-CoV-2, with genomic similarity to SARS-CoV and MERS-CoV, was identified as the etiological agent. The evolution of this pandemic has made it possible to verify the similarity in the pathophysiological mechanisms between these three viruses, identifying the Angiotensin-Converting protein-Enzyme 2 (ACE2) as the primary receptor for SARS-CoV-2. This age group is more prone to developing extrapulmonary complications from SARS-CoV-2 since the clinical and pathological findings suggest a particular relationship between greater expression of ACE2 and the comorbidities of chronic degenerative diseases and the greater expression of ACE2 at the level of the respiratory tract. It has also revealed the mechanisms by which the virus evades the innate immune response and the Th1-type adaptive response. The objective of this work was to analyze immunosenescence and its relationship with SARS-CoV-2 infection, through the review of the most recent articles (2021-2022), which describes the senescent state of the elderly. In addition, it intends to highlight the probable causes for which the most vulnerable population group (adults over 60 years of age) is more prone to presenting complications during the infection.
2019年底,中国武汉出现呼吸道感染疫情,进行性感染以成人为主,多发肺炎病例。一种与SARS-CoV和MERS-CoV具有基因组相似性的冠状病毒SARS-CoV-2被确定为病原。这次大流行的演变使得验证这三种病毒之间病理生理机制的相似性成为可能,并确定血管紧张素转换蛋白-酶2 (ACE2)是SARS-CoV-2的主要受体。这一年龄组更容易发生SARS-CoV-2的肺外并发症,因为临床和病理结果表明,ACE2的高表达与慢性退行性疾病的合共病以及呼吸道水平上ACE2的高表达之间存在特殊关系。这也揭示了病毒逃避先天免疫反应和th1型适应性反应的机制。本研究的目的是通过回顾近年来描述老年人衰老状态的最新文章(2021-2022),分析免疫衰老及其与SARS-CoV-2感染的关系。此外,它打算强调最脆弱人群(60岁以上的成年人)在感染期间更容易出现并发症的可能原因。
{"title":"Immunosenescence and ACE2 protein expression: Association with SARS-CoV-2 in older adults","authors":"Altamirano Gustavo Acosta, Rodríguez Carlos E Miguel, Reyes-Montes María del Rocío, Duarte-Escalante Esperanza, Acosta-Reyes Rocío, Torres-Estrella Carlos U, Valencia-Ledezma Omar E","doi":"10.17352/oja.000018","DOIUrl":"https://doi.org/10.17352/oja.000018","url":null,"abstract":"At the end of 2019, in Wuhan, China, an outbreak of cases of respiratory tract infection emerged and its progressive infection mainly affects adults, generating many cases of pneumonia. A type of coronavirus named SARS-CoV-2, with genomic similarity to SARS-CoV and MERS-CoV, was identified as the etiological agent. The evolution of this pandemic has made it possible to verify the similarity in the pathophysiological mechanisms between these three viruses, identifying the Angiotensin-Converting protein-Enzyme 2 (ACE2) as the primary receptor for SARS-CoV-2. This age group is more prone to developing extrapulmonary complications from SARS-CoV-2 since the clinical and pathological findings suggest a particular relationship between greater expression of ACE2 and the comorbidities of chronic degenerative diseases and the greater expression of ACE2 at the level of the respiratory tract. It has also revealed the mechanisms by which the virus evades the innate immune response and the Th1-type adaptive response. The objective of this work was to analyze immunosenescence and its relationship with SARS-CoV-2 infection, through the review of the most recent articles (2021-2022), which describes the senescent state of the elderly. In addition, it intends to highlight the probable causes for which the most vulnerable population group (adults over 60 years of age) is more prone to presenting complications during the infection.","PeriodicalId":151186,"journal":{"name":"Open Journal of Asthma","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123920115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is asthma over-diagnosed in Cyprus? A clinical study at the outpatient’s primary care level 塞浦路斯的哮喘是否被过度诊断?门诊初级保健水平的临床研究
Pub Date : 2022-09-28 DOI: 10.17352/oja.000017
Armeftis Charis, Lemessios Marinos, Anastas S. Christos, Gratziou Christina, Siafakas Nikolaos, Katsaounou Paraskevi, Bakakos Petros
Background: Although asthma is a common disease accurate diagnosis is missing and it has been reported that often it is over or under-diagnosed. Aim: To investigate if a physician’s diagnosis of asthma in Cyprus is correct by using a structured algorithm at the outpatient primary care level. Subjects and Methods: Sixty adults with a self-reported physician diagnosis of asthma, mean age of 47,8 years (29 males and 31 females) were included in the study. Medical history and physical examination, pre-post bronchodilation spirometry and methacholine bronchial challenge test was used to confirm or rule out the diagnosis as well as a three months follow-up. In addition, the cost of treatment was estimated. Results: Sixteen subjects (27%) had a positive pre-post bronchodilation spirometric test and were considered asthmatics. In 9 out of the 44 remaining subjects a positive Methacholine provocation test confirmed the diagnosis of asthma. The rest of the subjects (n = 35) went into a 3 months observational period during which only 2 showed asthmatic symptoms and were considered asthmatics by a second methacholine test that confirmed the diagnosis. Therefore, a correct asthma diagnosis was established in only 27(45%) of subjects. The annual average cost of medication for asthma confirmed the group was 313 euro/patient (171-454, 95% CI) and the average 2-year unnecessary (asthma ruled-out group) cost of treatment was approximately 297 euro/patient. (179-415, 95% CI). Conclusions: Physician-diagnosed asthma overestimates the actual prevalence of disease in adults in Cyprus since it was shown that more than half of the participants did not have Asthma. These individuals consume unneeded medications at a significant cost. Thus, the correct diagnosis of Asthma should be made by using more specific tests starting at the primary care level.
背景:虽然哮喘是一种常见的疾病,但缺乏准确的诊断,据报道,它经常被过度诊断或诊断不足。目的:调查如果医生的诊断哮喘在塞浦路斯是正确的使用结构化算法在门诊初级保健水平。研究对象和方法:60名自我报告患有哮喘的成年人,平均年龄为47,8岁(男性29名,女性31名)。病史、体格检查、支气管扩张前后肺活量测定和甲胆碱支气管激发试验确定或排除诊断,并随访3个月。此外,还估计了治疗费用。结果:16名受试者(27%)有支气管扩张前后肺活量测定阳性,被认为是哮喘患者。其余44名受试者中有9名甲胆碱激发试验阳性,证实了哮喘的诊断。其余受试者(n = 35)进入3个月的观察期,在此期间只有2人表现出哮喘症状,并通过第二次甲胆碱测试确认诊断为哮喘。因此,正确的哮喘诊断仅在27例(45%)受试者中建立。哮喘药物治疗的年平均费用证实该组为313欧元/患者(171-454,95% CI),平均2年不必要的(哮喘排除组)治疗费用约为297欧元/患者。(179-415, 95% ci)。结论:医生诊断的哮喘高估了塞浦路斯成人疾病的实际患病率,因为研究表明,超过一半的参与者没有哮喘。这些人消耗了大量不必要的药物。因此,对哮喘的正确诊断应该从初级保健水平开始使用更具体的测试。
{"title":"Is asthma over-diagnosed in Cyprus? A clinical study at the outpatient’s primary care level","authors":"Armeftis Charis, Lemessios Marinos, Anastas S. Christos, Gratziou Christina, Siafakas Nikolaos, Katsaounou Paraskevi, Bakakos Petros","doi":"10.17352/oja.000017","DOIUrl":"https://doi.org/10.17352/oja.000017","url":null,"abstract":"Background: Although asthma is a common disease accurate diagnosis is missing and it has been reported that often it is over or under-diagnosed. Aim: To investigate if a physician’s diagnosis of asthma in Cyprus is correct by using a structured algorithm at the outpatient primary care level. Subjects and Methods: Sixty adults with a self-reported physician diagnosis of asthma, mean age of 47,8 years (29 males and 31 females) were included in the study. Medical history and physical examination, pre-post bronchodilation spirometry and methacholine bronchial challenge test was used to confirm or rule out the diagnosis as well as a three months follow-up. In addition, the cost of treatment was estimated. Results: Sixteen subjects (27%) had a positive pre-post bronchodilation spirometric test and were considered asthmatics. In 9 out of the 44 remaining subjects a positive Methacholine provocation test confirmed the diagnosis of asthma. The rest of the subjects (n = 35) went into a 3 months observational period during which only 2 showed asthmatic symptoms and were considered asthmatics by a second methacholine test that confirmed the diagnosis. Therefore, a correct asthma diagnosis was established in only 27(45%) of subjects. The annual average cost of medication for asthma confirmed the group was 313 euro/patient (171-454, 95% CI) and the average 2-year unnecessary (asthma ruled-out group) cost of treatment was approximately 297 euro/patient. (179-415, 95% CI). Conclusions: Physician-diagnosed asthma overestimates the actual prevalence of disease in adults in Cyprus since it was shown that more than half of the participants did not have Asthma. These individuals consume unneeded medications at a significant cost. Thus, the correct diagnosis of Asthma should be made by using more specific tests starting at the primary care level.","PeriodicalId":151186,"journal":{"name":"Open Journal of Asthma","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122137189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of ST2 as a biomarker of respiratory dysfunction after interstitial pneumonia ST2作为间质性肺炎后呼吸功能障碍的生物标志物的作用
Pub Date : 2021-07-30 DOI: 10.17352/oja.000015
Maria Civita Cedrone, Luca Marino, M. Suppa, G. Bertazzoni
Through stern social restraint measures, Italy has recently overcome the epidemic peak of COVID-19 (Coronavirus Disease-19) respiratory syndrome induced by SARS-CoV-2 and the attention is progressively moving toward its sequelae, especially on pulmonary fibrosis and the associated pulmonary functional decline [1-3].
通过严厉的社会约束措施,意大利近期克服了SARS-CoV-2引发的COVID-19(冠状病毒病-19)呼吸综合征的流行高峰,并逐步将注意力转向其后遗症,特别是对肺纤维化和相关肺功能下降的关注[1-3]。
{"title":"Role of ST2 as a biomarker of respiratory dysfunction after interstitial pneumonia","authors":"Maria Civita Cedrone, Luca Marino, M. Suppa, G. Bertazzoni","doi":"10.17352/oja.000015","DOIUrl":"https://doi.org/10.17352/oja.000015","url":null,"abstract":"Through stern social restraint measures, Italy has recently overcome the epidemic peak of COVID-19 (Coronavirus Disease-19) respiratory syndrome induced by SARS-CoV-2 and the attention is progressively moving toward its sequelae, especially on pulmonary fibrosis and the associated pulmonary functional decline [1-3].","PeriodicalId":151186,"journal":{"name":"Open Journal of Asthma","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125213044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inclusion of steps to enhance mucus clearance may provide benefit for symptomatic COVID patients by reducing total viral load, time to recovery, risk of complications and transmission risk 纳入加强粘液清除的步骤可能会通过减少病毒总载量、恢复时间、并发症风险和传播风险,为有症状的COVID患者带来益处
Pub Date : 2021-07-15 DOI: 10.17352/oja.000014
Given John, S. Charles
The term immunity encompasses a vast array of cells and molecules which interact with the environment. There has been an explosion of knowledge in the past 50 years. The year 2021 has witnessed a world-wide scientifi c and humanitarian effort to defeat the COVID-19 pandemic. We owe much to Dr. Fauci and the worldwide scientifi c effort which has made monumental additions to knowledge of the internal immune system. Our hopes now rise as COVID vaccine distribution continues a direct result of research and development on the internal immune system.
免疫一词包括与环境相互作用的大量细胞和分子。在过去的50年里,知识爆发了。2021年是全世界为战胜COVID-19大流行作出科学和人道主义努力的一年。我们非常感谢福奇博士和全世界的科学努力,他们对人体内部免疫系统的知识做出了巨大的贡献。我们的希望现在上升了,因为COVID疫苗的分发继续是内部免疫系统研究和开发的直接结果。
{"title":"Inclusion of steps to enhance mucus clearance may provide benefit for symptomatic COVID patients by reducing total viral load, time to recovery, risk of complications and transmission risk","authors":"Given John, S. Charles","doi":"10.17352/oja.000014","DOIUrl":"https://doi.org/10.17352/oja.000014","url":null,"abstract":"The term immunity encompasses a vast array of cells and molecules which interact with the environment. There has been an explosion of knowledge in the past 50 years. The year 2021 has witnessed a world-wide scientifi c and humanitarian effort to defeat the COVID-19 pandemic. We owe much to Dr. Fauci and the worldwide scientifi c effort which has made monumental additions to knowledge of the internal immune system. Our hopes now rise as COVID vaccine distribution continues a direct result of research and development on the internal immune system.","PeriodicalId":151186,"journal":{"name":"Open Journal of Asthma","volume":"406 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134105797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Open Journal of Asthma
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1